National Cancer Institute; Amended Notice of Meeting, 34583 [E9-16894]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 135 / Thursday, July 16, 2009 / Notices
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Animal Models of Infectious
Diseases 2.
Date: July 29–31, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Crowne Plaza Hotel—Silver Spring,
8777 Georgia Avenue, Lincoln Ballroom,
Silver Spring, MD 20910.
Contact Person: Tracy A. Shahan, PhD,
MBA, Scientific Review Officer, Scientific
Review Program, NIH/NIAID/DHHS, Room
3121, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, 301–451–2606,
tshahan@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Ancillary Studies in
Immunomodulation Clinical Trials.
Date: August 12, 2009.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, 301–
402–7098, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–16830 Filed 7–15–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
erowe on DSK5CLS3C1PROD with NOTICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
VerDate Nov<24>2008
15:08 Jul 15, 2009
Jkt 217001
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Molecular Mechanisms of
HIV Latency.
Date: August 17, 2009.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Room 3133, Bethesda, MD
20817 (Telephone Conference Call).
Contact Person: Jay Bruce Sundstrom, PhD,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, Room
2217, 6700B Rockledge Drive, MSC–7616,
Bethesda, MD 20892–7616, 301–496–2550,
sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–16831 Filed 7–15–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, July
22, 2009, 8 a.m.to July 23, 2009, 5 p.m.,
Marriott Bethesda North Hotel &
Conference Center, Bethesda, MD which
was published in the Federal Register
on June 11, 2009, 74FR27806.
This notice is amended to change the
title from ‘‘NCI–ARRA Competitive
Revisions-Pre Clinical, Drug Discovery
& Imaging’’ to ‘‘NCI–ARRA Competitive
Revisions & Grand Opportunity-Pre
Clinical, Drug Discovery & Imaging’’.
The meeting is closed to the public.
Dated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–16894 Filed 7–15–09; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
34583
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Skeletal
Muscle Biology and Exercise Physiology
Competitive Revisions.
Date: July 23–27, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Priscilla B. Chen, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4104,
MSC 7814, Bethesda, MD 20892, (301) 435–
1787, chenp@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Skeletal
Biology I ARRA CR.
Date: July 23–26, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Daniel F. McDonald, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4110,
MSC 7814, Bethesda, MD 20892, (301) 435–
1215, mcdonald@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Skeletal
Biology II ARRA CR.
Date: July 23–26, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\16JYN1.SGM
16JYN1
]]>Agencies
[Federal Register Volume 74, Number 135 (Thursday, July 16, 2009)]
[Notices]
[Page 34583]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-16894]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Special Emphasis Panel, July 22, 2009, 8 a.m.to July
23, 2009, 5 p.m., Marriott Bethesda North Hotel & Conference Center,
Bethesda, MD which was published in the Federal Register on June 11,
2009, 74FR27806.
This notice is amended to change the title from ``NCI-ARRA
Competitive Revisions-Pre Clinical, Drug Discovery & Imaging'' to
``NCI-ARRA Competitive Revisions & Grand Opportunity-Pre Clinical, Drug
Discovery & Imaging''. The meeting is closed to the public.
Dated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-16894 Filed 7-15-09; 8:45 am]
BILLING CODE 4140-01-P
